Follow by Email

Thursday, August 25, 2016

#pennystocks making new 52-wk lows: $RCPI $SIXD $DRYS $FCSC #pennystock to read more:

Penny stocks making 52 week lows today:

Rock Creek Pharmaceuticals, Inc. (symbol: RCPI) ended the trading day today
(2016-08-25), at $0.0076 losing -10.5882%. The number of shares that
changed hands was 348,890, or about 0 times the average daily volume in the
stock. The end-of-day market cap was $1,300,000, about -99.3968% off the
highest price in the last 12 months. The stock has been trading at a range
between $0.0076 and $1.26. RCPI is in the Specialty Chemicals industry,
part of the Consumer Durables sector.


6D Global Technologies, Inc. (symbol: SIXD) ended the trading day today
(2016-08-25), at $0.1 losing 0.0%. The number of shares that changed hands
was 5, or about 0 times the average daily volume in the stock. The
end-of-day market cap was $7,820,000, about -97.14% off the highest price
in the last 12 months. The stock has been trading at a range between $0.1
and $3.5. SIXD is in the Professional Services industry, part of the
Consumer Services sector.


DryShips Inc. (symbol: DRYS) ended the trading day today (2016-08-25), at
$0.802 losing -5.647%. The number of shares that changed hands was 794,825,
or about 1 times the average daily volume in the stock. The end-of-day
market cap was $5,690,000, about -98.396% off the highest price in the last
12 months. The stock has been trading at a range between $0.802 and $50.0.
DRYS is in the Marine Transportation industry, part of the Transportation
sector. It first went public in 2005.


Fibrocell Science Inc (symbol: FCSC) ended the trading day today
(2016-08-25), at $0.89 losing -3.26%. The number of shares that changed
hands was 127,892, or about 0 times the average daily volume in the stock.
The end-of-day market cap was $39,070,000, about -86.81% off the highest
price in the last 12 months. The stock has been trading at a range between
$0.89 and $6.75. FCSC is in the Major Pharmaceuticals industry, part of the
Health Care sector.

No comments:

Post a Comment